Intestinal Epithelioid Cells
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 2 of these applications claim priority to application PCT/JP2017/045955, filed Dec 21, 2017. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 10,695,385 | Oral Cancer Vaccine In force · High confidence | National University Corporation Kobe University | In force | High confidence | ||
| US 10,889,805 | Intestinal Epithelioid Cells In force · High confidence | National Institutes of Biomedical Innovation, Health and Nutrition and Osaka University | In force | High confidence | ||
| US 12,303,613 | High-Strength Collagen Sponge In force · Medium confidence | Osaka University | In force | Medium confidence | ||
| US 11,559,603 | High-Strength Collagen Sponge In force · High confidence | Osaka University | In force | High confidence | ||
| US 11,666,646 | Cancer Therapy Utilizing Combination Of Oral Tumor Vaccine And Immunosuppression Inhibitor In force · High confidence | National University Corporation Kobe University | In force | High confidence | ||
| US 8,975,378 | Human Anti-Human Influenza Virus Antibody Lapsed Mar 10, 2019 on the fee record High confidence | Osaka University and The Research Foundation for Microbial Diseases of Osaka University | Lapsed Mar 10, 2019 on the fee record | High confidence | ||
| US 9,493,550 | Human Anti-Human Influenza Virus Antibody Lapsed Nov 15, 2020 on the fee record Medium confidence | Osaka University and The Research Foundation for Microbial Diseases of Osaka University | Lapsed Nov 15, 2020 on the fee record | Medium confidence | ||
| Application 13/375,661 | An Antigenic Peptide Derived From Influenza Virus And A Method For Selecting Anti-Influenza Virus Antibody Osaka University, The Research Foundation for Microbial Diseases of Osaka University and Mitsubishi Tanabe Pharma Corporation Abandoned Abandoned Jun 5, 2015 | Osaka University, The Research Foundation for Microbial Diseases of Osaka University and Mitsubishi Tanabe Pharma Corporation | Abandoned | Abandoned Jun 5, 2015 | ||
| Application 14/767,601 | Collagen Sponge Abandoned Abandoned Nov 12, 2020 | Osaka University | Abandoned | Abandoned Nov 12, 2020 | ||
| Application 14/779,017 | Method For Culturing Hepatoblast-Like Cells And Culture Product Thereof Abandoned Abandoned Dec 7, 2018 | Osaka University | Abandoned | Abandoned Dec 7, 2018 | ||
| 4 more patents in this group · Pro | ||||||
10 of 14 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 14, including 2 expired.
3 of these are in force and held by Osaka University.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.